No Data
No Data
Institutional Owners May Take Dramatic Actions as Zai Lab Limited's (NASDAQ:ZLAB) Recent 4.4% Drop Adds to One-year Losses
Key Insights Institutions' substantial holdings in Zai Lab implies that they have significant influence over the company's share price 51% of the business is held by the top 9 shareholders Ownersh
Form 144 | Zai Lab(ZLAB.US) Officer Proposes to Sell 213.35K in Common Stocks
SEC FILLINGS DISCLOSED/ May 14, $ZAI LAB LIMITED(ZAILF.US)$、$Zai Lab(ZLAB.US)$ Officer Edmondson Frazor Titus III intends to sell 10,000 shares of its common stock on May 14, with a total market value
Zai Lab Shares Rise 11% After Augtyro NDA Approved in China
By Chris Wack Zai Lab Limited shares were up 11% to $22.27 after the company said that the National Medical Products Administration in China has approved the New Drug Application for Augtyro repotrec
Zai Lab Limited (NASDAQ:ZLAB) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
Zai Lab Limited (NASDAQ:ZLAB) Q1 2024 Earnings Call Transcript
Zai Lab Limited (ZLAB) Q1 2024 Earnings Call Transcript
Zai Lab Limited (ZLAB) Q1 2024 Earnings Call Transcript
No Data